Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

CYTKCYTK
Showing 8 of 15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in CYTOKINETICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 6.9M shares of CYTK (CYTOKINETICS INC), worth $590.5M as of 2026-Q2. The position was decreased (-13.5% shares). CYTK represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$590.5M

Current Shares

6.9M

Total Value Change

+$180M

Total Shares Change

-843,200

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6.9M
-13.5%
$590.5M0.1%$85.19
0
2026-Q1
Increased
8M
+0.9%
$527.9M0.1%$65.91
32
2025-Q4
Increased
7.9M
+7.1%
$504.3M0.1%$63.54
34
2025-Q3
Decreased
7.4M
-5.3%
$407.2M0.1%$54.96
0
2025-Q2
Decreased
7.8M
-2.0%
$258.6M0.0%$33.04
0
2025-Q1
Increased
8M
+1.3%
$321.1M0.1%$40.19
31
2024-Q4
Increased
7.9M
+1.5%
$371.1M0.1%$47.04
31
2024-Q3
Increased
7.8M
+3.5%
$410.5M0.1%$52.80
32

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used